just because a peptide showed results with animals, rats, or cells in a lab, that doesnt mean its safe or effective in your body
The selective action of AOD-9604 on fat tissue, without growth hormone receptor activation, eliminates these concerning safety issues
Packaged in a sterile, sealed vial, AOD-9604 is designed to maintain maximum stability, consistency, and integrity during research applications
AOD-9604 is a good example: its targeted mechanism, clean safety record, and emerging joint data continue to make it a useful tool in integrative and functional medicine settings
Because it does not suppress appetite, it can theoretically be combined with GLP-1 agonists to add a lipolytic component to the appetite suppression mechanism, though clinical data on this combination is lacking